These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32441311)

  • 1. Human T cells interacting with HNSCC-derived mesenchymal stromal cells acquire tissue-resident memory like properties.
    Mazzoni A; Maggi L; Montaini G; Ramazzotti M; Capone M; Vanni A; Locatello LG; Barra G; De Palma R; Gallo O; Cosmi L; Liotta F; Annunziato F
    Eur J Immunol; 2020 Oct; 50(10):1571-1579. PubMed ID: 32441311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.
    Ida S; Takahashi H; Kawabata-Iwakawa R; Mito I; Tada H; Chikamatsu K
    Oral Oncol; 2021 Nov; 122():105508. PubMed ID: 34507204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.
    Mann JE; Smith JD; Birkeland AC; Bellile E; Swiecicki P; Mierzwa M; Chinn SB; Shuman AG; Malloy KM; Casper KA; McLean SA; Moyer JS; Wolf GT; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
    Cancer Immunol Immunother; 2019 Feb; 68(2):213-220. PubMed ID: 30361882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR6 deficiency impairs cancer vaccine efficacy and CD8
    Karaki S; Blanc C; Tran T; Galy-Fauroux I; Mougel A; Dransart E; Anson M; Tanchot C; Paolini L; Gruel N; Gibault L; Lepimpec-Barhes F; Fabre E; Benhamouda N; Badoual C; Damotte D; Donnadieu E; Kobold S; Mami-Chouaib F; Golub R; Johannes L; Tartour E
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma.
    Lai C; Coltart G; Shapanis A; Healy C; Alabdulkareem A; Selvendran S; Theaker J; Sommerlad M; Rose-Zerilli M; Al-Shamkhani A; Healy E
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-resident memory CD8
    Wang T; Shen Y; Luyten S; Yang Y; Jiang X
    Pharmacol Res; 2020 Sep; 159():104876. PubMed ID: 32422340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103-CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease.
    von Witzleben A; Ellis M; Thomas GJ; Hoffmann TK; Jackson R; Laban S; Ottensmeier CH
    Clin Cancer Res; 2024 Jan; 30(1):224-234. PubMed ID: 37874322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
    Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty Acid Oxidation Controls CD8
    Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W
    Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resident memory T cells, critical components in tumor immunology.
    Mami-Chouaib F; Blanc C; Corgnac S; Hans S; Malenica I; Granier C; Tihy I; Tartour E
    J Immunother Cancer; 2018 Sep; 6(1):87. PubMed ID: 30180905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem-like cells evade CD8
    Corgnac S; Damei I; Gros G; Caidi A; Terry S; Chouaib S; Deloger M; Mami-Chouaib F
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35418483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of CD69
    Kim HD; Jeong S; Park S; Lee YJ; Ju YS; Kim D; Song GW; Lee JH; Kim SY; Shin J; Shin EC; Hwang S; Yoo C; Park SH
    Liver Int; 2021 Apr; 41(4):764-776. PubMed ID: 33548061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human CD4
    Klicznik MM; Morawski PA; Höllbacher B; Varkhande SR; Motley SJ; Kuri-Cervantes L; Goodwin E; Rosenblum MD; Long SA; Brachtl G; Duhen T; Betts MR; Campbell DJ; Gratz IK
    Sci Immunol; 2019 Jul; 4(37):. PubMed ID: 31278120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer.
    Junker N; Andersen MH; Wenandy L; Dombernowsky SL; Kiss K; Sørensen CH; Therkildsen MH; Von Buchwald C; Andersen E; Straten PT; Svane IM
    Cytotherapy; 2011 Aug; 13(7):822-34. PubMed ID: 21428850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
    Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
    Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-Resident Memory CD8
    Topham DJ; Reilly EC
    Front Immunol; 2018; 9():515. PubMed ID: 29632527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy.
    Damei I; Trickovic T; Mami-Chouaib F; Corgnac S
    Front Immunol; 2023; 14():1205984. PubMed ID: 37545498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.